Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
EUR 1 - 1
Notice Type:
Contract award notice
Published Date:
02 August 2017
Closing Date:
Location(s):
FR FRANCE
FR9 DÉPARTEMENTS D'OUTRE-MER (FR FRANCE)
Description:

Fourniture de Baclofène et Prednisolone, au groupement de commande des CHU et principaux CH — bAPRE.


Myorelaxant Baclofène 0.05mg injectable IT

Sl1: Baclofène 0,05mg injectable IT — qté est. 1ère période: 1 485.


Myorelaxant Baclofène injectable 10mg/20ml

Sl 1: Baclofène 10mg/20ml — qté est. 1ère période: 1 170.


Myorelaxant Baclofène injectable 10mg/5ml

Sl 1: Baclofène 10mg/5ml — qté est. 1ère période: 13 923.


Myorelaxant Baclofène injectable 40mg/20ml

Sl 1: Baclofène 40mg/20ml — qté est. 1ère période: 48.


Prednisolone orale (forme orodispersible) faible dosage

Sl 1: 5 MG — qté est. 1ère période: 362 809.


Prednisolone orale (forme orodispersible) fort dosage

Sl 1: 20 MG — qté est. 1ère période: 1 778 617.

Awarded to:
Myorelaxant Baclofène injectable 10mg/5ml
Aguettant Laboratoire, Saint-Fons Cedex (FR)
Myorelaxant Baclofène injectable 10mg/20ml
Laboratoire Aguettant, Saint-Fons Cedex (FR)
Myorelaxant Baclofène 0,05mg injectable IT
Novartis Pharma SA, Rueil Malmaison (FR)
Prednisolone orale (forme orodispersible) faible dosage
Sanofi Aventis France, Gentilly (FR)
Prednisolone orale (forme orodispersible) fort dosage
Sanofi Aventis France, Gentilly (FR)
Download full details as .pdf
The Buyer:
CHU de Bordeaux
CPV Code(s):
33600000 - Pharmaceutical products